our Premium Content: News alerts, weekly reports and conference planners
GENE:
RTN3 (Reticulon 3)
i
Other names: RTN3, Reticulon 3, NSPLII, NSPL2, ASYIP, HAP, Neuroendocrine-Specific Protein-Like 2, Homolog Of ASY Protein, NSP-Like Protein II, RTN3-A1, Neuroendocrine-Specific Protein-Like II, ASY Interacting Protein, NSP-Like Protein 2, Reticulon-3, Isoforme III
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Downregulation of RTN3 lead to stabilization of DHCR7 and elevate cholesterol concentration, activating EGFR/ERK pathway and contributes to progression of thyroid cancer, which can be rescued by HMG-CoA reductase inhibitor Simvastatin. We identified RTN3 as a tumor suppressor and a biomarker of sensitivity to MEK inhibitors and verified the role of cholesterol in drug resistance. The combination of statins provides a novel therapeutic method in patients resistant to MEK inhibitors.
The developed NDS is a powerful tool for assessing the risk and clinical treatment of HCC. Furthermore, we identified and analyzed the feasibility of the critical gene RTN3 in NDS as a molecular marker for HCC.